• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[获得性血管性血友病综合征]

[Acquired von Willebrand syndrome].

作者信息

de Lange D W, Fijnheer R, Wittebol S

机构信息

Universitair Medisch Centrum, afd. Interne Geneeskunde, F02.107, Heidelberglaan 100, 3508 GA Utrecht.

出版信息

Ned Tijdschr Geneeskd. 2003 Sep 13;147(37):1808-11.

PMID:14526622
Abstract

Two patients, a man aged 69 and a woman aged 64, were diagnosed with Von-Willebrand syndrome caused by monoclonal gammopathy. The man, who was admitted for hip surgery, had a history of long episodes of epistaxis. The patient was treated with immunoglobulin and the hip operation was carried out with no complications. The woman suffered from haemorrhagic diathesis. She was advised that should she undergo an invasive procedure then treatment with a prophylactic with intravenous immunoglobulin or Von-Willebrand factor (VWF)/factor-VIII-concentrates must be administered. Acquired Von-Willebrand syndrome is a rare condition with an estimated prevalence of 0.04-0.13%. It is linked to a large number of underlying diseases such as paraproteinaemia, multiple myeloma (Kahler's disease), myeloproliferative disease, lymphoproliferative disease, auto-immune disease, solid tumours and hypothyroidism. Recognition depends on a careful case-history and identification of the underlying disease. For its diagnosis VWF antigen. VWF propeptide, activated partial thromboplastin time and factor VIII are of importance. Technically, it is difficult to show the presence of VWF antibodies as it concerns a heterogeneous group of antibodies. There are two pillars of treatment: symptomatic treatment of the bleeding tendencies using desmopressin, VWF-concentrate or intravenous gammaglobulin, and treatment of the underlying disease. The latter form of treatment can lead to acquired Von-Willebrand-syndrome disappearing altogether.

摘要

两名患者,一名69岁男性和一名64岁女性,被诊断患有由单克隆丙种球蛋白病引起的血管性血友病。该男性因髋关节手术入院,有长期鼻出血病史。患者接受了免疫球蛋白治疗,髋关节手术顺利,未出现并发症。该女性患有出血素质。她被告知,如果她接受侵入性手术,那么必须给予静脉注射免疫球蛋白或血管性血友病因子(VWF)/凝血因子VIII浓缩物进行预防性治疗。获得性血管性血友病综合征是一种罕见疾病,估计患病率为0.04 - 0.13%。它与大量潜在疾病有关,如副蛋白血症、多发性骨髓瘤(卡勒病)、骨髓增殖性疾病、淋巴增殖性疾病、自身免疫性疾病、实体瘤和甲状腺功能减退症。诊断依赖于仔细的病史询问和潜在疾病的识别。对于其诊断,VWF抗原、VWF前肽、活化部分凝血活酶时间和凝血因子VIII很重要。从技术上讲,由于涉及一组异质性抗体,很难检测到VWF抗体的存在。治疗有两大支柱:使用去氨加压素、VWF浓缩物或静脉注射丙种球蛋白对出血倾向进行对症治疗,以及对潜在疾病进行治疗。后一种治疗形式可导致获得性血管性血友病综合征完全消失。

相似文献

1
[Acquired von Willebrand syndrome].[获得性血管性血友病综合征]
Ned Tijdschr Geneeskd. 2003 Sep 13;147(37):1808-11.
2
Acquired von Willebrand disease--hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion.获得性血管性血友病——大剂量免疫球蛋白、去氨加压素和持续输注凝血因子浓缩物用于大型骨科手术的止血管理。
Am J Hematol. 2002 May;70(1):64-71. doi: 10.1002/ajh.10074.
3
Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.获得性血管性血友病综合征:临床特征、病因、病理生理学、分类及管理
Best Pract Res Clin Haematol. 2001 Jun;14(2):401-36. doi: 10.1053/beha.2001.0141.
4
Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies.获得性血管性血友病的病因、发病机制及诊断:一项旨在确立最有效治疗策略的前瞻性诊断检查
Acta Haematol. 2009;121(2-3):177-82. doi: 10.1159/000214858. Epub 2009 Jun 8.
5
Acquired von Willebrand syndrome: features and management.获得性血管性血友病综合征:特征与管理
Am J Hematol. 2006 Aug;81(8):616-23. doi: 10.1002/ajh.20455.
6
Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3.1型、2型和3型血管性血友病患者出血治疗和预防中静脉注射去氨加压素及血管性血友病因子/凝血因子VIII浓缩物的评估指南
Semin Thromb Hemost. 2006 Sep;32(6):636-45. doi: 10.1055/s-2006-949669.
7
Acquired von Willebrand syndrome: diagnostic problems and therapeutic options.获得性血管性血友病综合征:诊断问题与治疗选择
Am J Hematol. 2007 Jan;82(1):55-8. doi: 10.1002/ajh.20760.
8
Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.静脉注射去氨加压素和因子VIII-血管性血友病因子浓缩物用于治疗和预防1型、2型和3型血管性血友病患者的出血。
Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. doi: 10.1177/1076029606296399.
9
Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.在手术环境中使用去氨加压素和血管性血友病因子-凝血因子VIII浓缩物治疗1型、2型和3型血管性血友病患者。
Acta Haematol. 2009;121(2-3):167-76. doi: 10.1159/000214857. Epub 2009 Jun 8.
10
Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches.意义未明的单克隆丙种球蛋白病患者获得性血管性血友病综合征的治疗:三种不同治疗方法的比较
Blood. 1998 Oct 15;92(8):2707-11.